Are nitrates safe in patients who use sildenafil? Maybe

Critical Care Medicine

Volumn 35, Issue 8, 2007, Pages 1988-1990

  Werns, Steven W ^a  

^a Division of Female Pelvic Medicine and Reconstructive Surgery   (United States)

Author keywords

Coronary artery disease; Erectile dysfunction; Nitrates; Nitroglycerin; Pphosphodiesterase 5 inhibitor; Sildenafil

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GLYCERYL TRINITRATE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO; SILDENAFIL;

ACUTE CORONARY SYNDROME; ANGINA PECTORIS; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG DOSE ESCALATION; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; EDITORIAL; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; HYPOTENSION; MORTALITY; PATIENT SAFETY; PRIORITY JOURNAL; UNSTABLE ANGINA PECTORIS;

CORONARY DISEASE; DRUG INTERACTIONS; DRUG TOXICITY; HUMANS; MALE; NITROGLYCERIN; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PURINES; SULFONES; VASODILATOR AGENTS;

EID: 34547662011     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000277252.15724.F1     Document Type: Editorial

References (21)

1. Kloner RA: Cardiovascular effects of the 3 phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunction. Circulation 2004; 110:3149-3155
2. Michelakis E, Tymchak W, Lien D, et al: Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: Comparison with inhaled nitric oxide. Circulation 2002; 105:2398-2403
3. Mikhail GW, Prasad SK, Li W, et al: Clinical and haemodynamic effects of sildenafil in pulmonary hypertension: Acute and midterm effects. Eur Heart J 2004; 25:431-436
4. Galie N, Ghofrani HA, Torbicki A, et al: Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 2005; 353:2148-2157
5. Thompson IM, Tangen CM, Goodman PJ, et al: Erectile dysfunction and subsequent cardiovascular disease. JAMA 2005; 294:2996-3002
6. Herrmann HC, Chang G, Klugherz BD, et al: Hemodynamic effects of sildenafil in men with severe coronary artery disease. N Engl J Med 2000; 342:1622-1626
7. Halcox JP, Nour KR, Zalos G, et al: The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia. J Am Coll Cardiol 2002; 40:1232-1240
8. Arruda-Olson AM, Mahoney DW, Nehra A, et al: Cardiovascular effects of sildenafil during exercise in men with known or probable coronary artery disease: A randomized crossover trial. JAMA 2002; 287:719-725
9. Abrams J: Beneficial actions of nitrates in cardiovascular disease. Am J Cardiol 1996; 77:31C-37C
10. Parker JD, Parker JO: Nitrate therapy for stable angina pectoris. N Engl J Med 1998; 338:520-531
11. Cohn JN, Archibald DG, Ziesche S, et al: Effect of vasodilator therapy on mortality in chronic congestive heart failure: Results of a Veterans Administration Cooperative Study. N Engl J Med 1986; 314:1547-1552
12. Taylor AL, Ziesche S, Yancy C, et al: Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med 2004; 351:2049-2057
13. Antman EM, Anbe DT, Armstrong PW, et al: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004; 110:e82-e292
14. Webb DJ, Muirhead GJ, Wulff M, et al: Sildenafil citrate potentiates the hypotensive effects of nitric oxide donor drugs in male patients with stable angina. J Am Coll Cardiol 2000; 36:25-31
15. Kloner RA, Hutter AM, Emmick JT, et al: Time course of the interaction between tadalafil and nitrates. J Am Coll Cardiol 2003; 42:1855-1860
16. Cheitlin MD, Hutter AM Jr, Brindis RG, et al: Use of sildenafil (Viagra) in patients with cardiovascular disease. Circulation 1999; 99:168-177
17. Kostis JB, Jackson G, Rosen R, et al: Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol 2005; 96:313-321
18. Muller JE, Mittleman MA, Maclure M, et al: Triggering myocardial infarction by sexual activity: Low absolute risk and prevention by regular physical exertion. JAMA 1996; 275:1405-1409
19. DeBusk RF: Sexual activity in patients with angina. JAMA 2003; 290:3129-3132
20. Parker JD, Bart BA, Webb DJ, et al: Safety of intravenous nitroglycerin after administrationof sildenafil citrate to men with coronary artery disease: A double-blind, placebo-controlled, randomized, crossover trial. Crit Care Med 2007; 35:1863-1868
21. Gibler WB, Cannon CP, Blomkalns AL, et al: Practical implementation of the guidelines for unstable angina/non-ST-segment elevation myocardial infarction in the emergency department: a scientific statement from the American Heart Association Council on Clinical Cardiology (Subcommittee on Acute Cardiac Care), Council on Cardiovascular Nursing, and Quality of Care and Outcomes Research Interdisciplinary Working Group, in Collaboration With the Society of Chest Pain Centers. Circulation 2005; 111:2699-2710